12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Deals

Protalix, Pfizer deal

Protalix received a $25 million milestone from Pfizer under a November 2009 deal granting the pharma exclusive, worldwide rights, excluding Israel,...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >